BELFAST centenarians: A case of optimal cardiovascular risk?

Current Pharmaceutical Design

Volumn 16, Issue 7, 2010, Pages 789-795

  Bennati, E ^a,b   Murphy, A ^a   Cambien, F ^c   Whitehead, A S ^d   Archbold, G P R ^e   Young, I S ^a   Rea, I M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF GENOA   (Italy)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

ACE; Anti oxidants; Apoe; BELFAST; Centenarians; Cholesterol; Malondiadehyde; Mortality

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; LIPOPROTEIN; MALONALDEHYDE; METHYLENE TETRAFOLATE DEHYDROGENASE REDUCTASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

AGED; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

EID: 77950295357     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883697     Document Type: Article

References (46)

1. Oeppen J, Vaupel JW. DEMOGRAPHY: Enhanced: broken limits to life expectancy. Science 2002; 296: 1029-1031
2. Wilcox BJ, Wilcox DC, Suzuki M. In: The Okinawa Program: How the World's Longest-Lived People Achieve Everlasting Health. New York: Clarkson Potter Publishers, 2001.
3. Caselli G, Pozzi L, Vaupel JW, Deiana L Pes G, Carru C, et al. Family clustering in Sardinian longevity: a genealogical approach. Exp. Gerontol 2006; 41: 727-736
4. Passarino G, Calignano C, Vallone A, Franceschi C, Jeune B, Robine JM, et al. Male/female ratio in centenarians: a possible role played by population genetic structure. Exp Gerontol 2002; 37: 1283-1289
5. The Registrar General Northern Ireland. Eighty third Annual Report of the Registrar General 2004. HMSO 2004.
6. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
7. Central Statistics Office Ireland, 2006; Available at: (http://www.cso.ie/)
8. Kee F, Patterson C, Collins B. Colorectal cancer in the north and south of Ireland 1950-1984. J Epidemiol Commun Health 1990; 44: 220-223
9. Cullen CG, Middleton D, Savage DA. Frequency and associations of HLA class II TaqI allogenotypes in the Northern Ireland population. Hum Immunol 1990; 2: 92-102.
10. Rea IM, McMaster D, Woodside JV, Young IS, Archbold GPR, Linton T, et al. Community living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70-89 year old subjects. Atherosclerosis 2000; 149: 207-214
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Psychiatr Res 1975; 3: 189-198
12. Ligthart GL, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech Ageing Dev 1984; 28: 47-55.
13. Rea IM, Gillen S, Clarke E. Anthropometric measurements from a cross-sectional survey of community-living subjects aged >90 years of age. Eur J Clin Nutr 1997; 51: 102-106
14. Dietary Reference Values of Food and Nutrition for the United Kingdom, Department of Health. Report on Health and Social Subjects. London: HMSO 1991.
15. D McMaster D, Bell N, Anderson P, Love AH. Automated measurement of two indicators of human selenium status and applicability to population studies. Clin Chem 1990; 36: 211-216
16. Rea IM, McMaster D, Donnelly J, McGrath LT, Young IS. Malondialdehyde and measures of antioxidant activity in subjects from the belfast elderly longitudinal free-living aging study. Ann NY Acad Sci 2004; 1019: 392-395
17. McGrath LT, Brennan GM, Donnelly JP, Johnston GD, Hayes JR, McVeigh GE. Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus. Arteriosclerosis 1996; 121: 275-283
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 3: 1215.
19. Ilveskoski E, Perola M, Lehtimaki T, Laippala P, Savolainen V, Pajarinen J, et al. Age-dependent association of apolipo-protein E genotype with coronary and aorticatherosclerosis in middle-aged men: an autopsy study. Circulation 1999; 6: 608-613
20. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644
21. Heijmans BT, Gussekloo J, Kluft C, Droog S, Lagaay AM, Knook DL, et al. Mortality risk in men is associated with a common mutation in themethylene-tetrahydro-folate reductase gene (MTHFR). Eur J Hum Genet 1999; 2: 197-204.
22. Rea IM, Mc Dowell I, McMaster D, Smye M, Stout R, Evans AE, et al. Monitoring of Cardiovascular trends study group. Apolipo-protein E alleles in nonagenarian subjects in the Belfast ElderlyLongitudinal Free-living Ageing Study (BELFAST). Mech Ageing Dev 2001; 122: 1367-1372
23. Vaupel JW. Personal communication. 2006.
24. Gjonca A, Tomassin C, Toson B, Smallwood S. Sex differences in mortality, a comparison of the United Kingdom and other developed countries. Health Stat Q 2005; 26: 6-16.
25. Jha M, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet 2006; 368: 367-370
26. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847
27. Lloyd-Jones DM, Wilson PW, Larson MG, Beise A, Leip EP, D'Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004; 94: 20-24
28. Wood D, De Backer G, Faergemann O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998; 19: 1434-1503
29. Pearlman BL. The new cholesterol guidelines. Applying them in clinical practice. Postgrad Med 2002; 112: 13-26.
30. Schachter F, Faure-Delenauf L, Guenot F, Rouger H, Froguet P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the ApoE and ACE loci. Nature Genet 1994; 6: 29-32.
31. Rebeck GW, Perls TT, West WL, Sodhi P, Lipsitz LA, Growdon J, et al. The prevalence of apolioprotein E4 in very old Alzheimers disease and non-demented populations. Neurology 1994; 44: 1513-1516
32. Jian-Gang Z, Yong-Xing M, Chuan-Fu W, Pei-Fang L, Song-Bai Z, Nui-Fan G, et al. Apolipoprotein E and longevity among Han Chinese population. Mech Ageing Dev 1998; 104: 159-167
33. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci 2001; 56: M75-8.
34. Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997; 129: 177-183
35. Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, et al. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet 107: 201-208
36. Kluijtmans LA, Whitehead AS. Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly. Atherosclerosis 2002; 146: 395-397
37. Luft FC. Bad genes, good people, association, linkage, longevity and the prevention of cardiovascular disease. Clin Exp Pharmacol Physiol 1999; 26: 576-579
38. Brattstrom L, Zhang Y, Hurtig M, Refsum H, Ostensson S, Fransson L, et al. A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis 1998; 141: 315-319
39. Viiri LE, Loimaala A, Nenonen A, Islam S, Vuori I, Karhunen PJ, et al. The association of the apoli-poprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 2005; 179: 161-167
40. Elosua R, Ordovas JML, Cupples A, Fox CS, Polak JK, Wolf PA, et al. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res 2004; 45: 1868-1875
41. Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am J Epidemiol 2006; 164(4): 342-348
42. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann NY Acad Sci 2006; 1067: 10-21.
43. Barzilai N, Gabriely I, Gabriely M, Iankowitz N, Sorkin JD. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc 2001; 49(1): 76-79
44. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005; 579(12): 2541-2545
45. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE. 17 β-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2 [MAPK]/ NFκB cascade. Aging Cell 2005; 4: 113-118
46. Ahluwalia A, Clodfelter KH, Waxman DJ. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol Endocrinol 2004; (3): 747-760